B.R.A.I.N. Biotechnology Research And Information Network AG (ETR:DE000520) | WebDisclosure

Basculer en Français

10804	Companies
233853	Keywords
162555	Articles
124901	Press releases

Headlines Articles Press releases B.R.A.I.N. Biotechnology Research And Information Network AG

Home
Companies
B.R.A.I.N. Biotechnology Research And Information Network AG

PRESS RELEASE

published on 02/25/2026 at 07:30, 5 months 8 days ago

BRAIN Biotech announces 3M 25/26 results and breakthrough at BioIncubator company SolasCure: Aurase Wound Gel showing strong clinical evidence of superior debridement and healing in chronic wounds
BRAIN Biotech's Q1 25/26 results show revenue decline but improved EBITDA. Breakthrough Aurase Wound Gel by SolasCure for chronic wounds. BRAIN BioIncubator segment thrives

EBITDA BRAIN Biotech Q1 Results SolasCure Aurase Wound Gel
BRIEF

published on 01/14/2026 at 07:35, 6 months 22 days ago

BRAIN Biotech AG fait preuve de résilience face aux défis économiques de l'exercice 2024/25

Baisse Des Revenus BRAIN Biotech AG Contrôle Des Coûts Exercice Financier 2024/25 Incubateur BRAINBio
BRIEF

published on 01/14/2026 at 07:35, 6 months 22 days ago

BRAIN Biotech AG Shows Resilience Amid Economic Challenges in FY 2024/25

Revenue Decline BRAIN Biotech AG Cost Control Financial Year 2024/25 BRAINBioIncubator
PRESS RELEASE

published on 01/14/2026 at 07:30, 6 months 22 days ago

FY 2024/25: BRAIN Biotech AG benefits from successful monetization of projects and strong corporate cost control
BRAIN Biotech AG reports FY 2024/25 financial results showing successful project monetization and cost control measures. Decline in revenues offset by strong cash position

Financial Results Revenue Decline BRAIN Biotech AG Cost Control Project Monetization
BRIEF

published on 09/03/2025 at 09:35, 11 months 2 days ago

BRAIN Biotech AG Names Johan Jansén-Storbacka as EVP

Biotechnology BRAIN Biotech AG Executive Appointment Johan Jansén-Storbacka Enzyme Products
BRIEF

published on 09/03/2025 at 09:35, 11 months 2 days ago

BRAIN Biotech AG nomme Johan Jansén-Storbacka au poste de vice-président exécutif

Biotechnologie BRAIN Biotech AG Nomination De L'exécutif Johan Jansén-Storbacka Produits Enzymatiques
PRESS RELEASE

published on 09/03/2025 at 09:30, 11 months 2 days ago

BRAIN Biotech AG appoints Johan Jansén-Storbacka as Executive Vice President of the BRAINBiocatalysts´ enzyme products business
BRAIN Biotech AG appoints Johan Jansén-Storbacka as Executive Vice President of the BRAINBiocatalysts´ enzyme products business on September 1, 2025, succeeding Rod Sears-Black. Johan brings 20+ years of biotechnology experience

BRAIN Biotech Executive Vice President Johan Jansén-Storbacka Enzyme Products Biocatalysts
BRIEF

published on 08/28/2025 at 07:35, 11 months 8 days ago

BRAIN Biotech Reports Solid Q3 Revenue Growth in BRAINBiocatalysts Segment

Financial Results BRAIN Biotech AG Enzyme Business BRAINBiocatalysts Q3 Revenue Growth
BRIEF

published on 08/28/2025 at 07:35, 11 months 8 days ago

BRAIN Biotech annonce une solide croissance de son chiffre d'affaires au troisième trimestre dans le segment BRAINBiocatalysts

Résultats Financiers BRAIN Biotech AG Entreprise D'enzymes CERVEAUBiocatalyseurs Croissance Du Chiffre D'affaires Au Troisième Trimestre
PRESS RELEASE

published on 08/28/2025 at 07:30, 11 months 8 days ago

BRAIN Biotech reports dynamic Q3 revenue growth in core segment BRAINBiocatalysts
BRAIN Biotech AG reports dynamic Q3 revenue growth in core segment BRAINBiocatalysts. Despite economic challenges, the company shows positive EBITDA results

Financial Results EBITDA Revenue Growth BRAIN Biotech AG BRAINBiocatalysts

Accesswire

Published on 08/05/2026 at 22:35, 22 minutes ago

Cielo Selects Amdocs to Bring Intelligent Connectivity to Its Entire Brazilian Payment Terminal Network
Published on 08/05/2026 at 22:30, 27 minutes ago

Optimum Transforms Customer Bill Experience with AI-Enhanced Platform Powered by Amdocs aOS Cognitive Core
Published on 08/05/2026 at 22:25, 32 minutes ago

Lumen Extends Multi-Cloud Strategy with Amdocs, Modernizing Enterprise Service Orchestration
Published on 08/05/2026 at 22:20, 37 minutes ago

PLDT Home Selects Amdocs to Modernize Core Business Platform, Advancing Cloud-Ready Transformation
Published on 08/05/2026 at 22:15, 42 minutes ago

Sunrise Extends its Strategic Collaboration with Amdocs, Advancing its CRM Evolution with aOS

View all ACCESSWIRE

EQS Group

Published on 08/05/2026 at 19:14, 3 hours 43 minutes ago

2CRSi informe le marché sur la gouvernance de la société AETHER Infrastructures et l’avancement du projet AETHER auquel 2CRSi participe comme membre du consortium
Published on 08/05/2026 at 19:14, 3 hours 43 minutes ago

2CRSi informs the market about the governance of AETHER Infrastructures and the progress of the AETHER project in which 2CRSi takes part as a member of the consortium
Published on 08/05/2026 at 18:45, 4 hours 12 minutes ago

Holding(s) in Company
Published on 08/05/2026 at 18:30, 4 hours 26 minutes ago

Avolta enters Kolkata Airport, growing duty-free presence in India
Published on 08/05/2026 at 18:29, 4 hours 28 minutes ago

Designated Person Notification

Les Echos

Published on 08/05/2026 at 18:00, 4 hours 57 minutes ago

Informations relatives au nombre total de droits de vote et d’actions composant le capital social au 31 juillet 2026
Published on 08/05/2026 at 18:00, 4 hours 57 minutes ago

Information concerning the total number of voting rights and shares in the share capital as of July 31, 2026
Published on 08/05/2026 at 17:49, 5 hours 7 minutes ago

Mersen : nombre d'actions et de droits de vote au 31 juillet 2026
Published on 08/05/2026 at 17:49, 5 hours 7 minutes ago

Mersen: Number of shares and voting rights as of July 31, 2026
Published on 08/05/2026 at 17:45, 5 hours 12 minutes ago

INFORMATION MENSUELLE RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET AU NOMBRE D’ACTIONS COMPOSANT LE CAPITAL SOCIAL

View all LES ECHOS COMFI WIRE